|
Barter Transaction
|
12 Months Ended |
|---|---|
|
Dec. 31, 2013
|
|
| Nonmonetary Transactions [Abstract] | |
| Barter Transaction |
9. BARTER TRANSACTION During 2012, we entered into a barter transaction, exchanging laboratory capital assets with a zero net book value for barter credits on future apatorsen preclinical research services. The credits were recorded at the fair value of the laboratory capital assets exchanged, in accordance with ASC 845, “Nonmonetary Transactions” resulting in other income of $0.2 million, which was recorded in our Consolidated Statement of Loss, in 2012. As of December 31, 2013 all the barter credits had been utilized in exchange for preclinical research services related to apatorsen. |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for exchanges with other entities that involve principally nonmonetary assets or liabilities or relate to a transfer of nonmonetary assets for which the entity receives no assets in return. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|